Lower radiation dose for children with CNS germinoma
Treatments studied
Part of Cancer, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial will see if giving a lower dose of radiation therapy can still effectively treat children and young adults with a type of brain tumor called germinoma. The goal is to reduce side effects while keeping the cancer under control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 3 and 30 years old.
- You must have a newly diagnosed, localized germinoma in certain areas of the brain (like the pineal or suprasellar region).
- Your blood or spinal fluid must have certain levels of tumor markers (HCG-beta and AFP) that are within specific ranges.
- You must be in generally good health (able to carry out daily activities) with adequate kidney, liver, and blood cell counts.
- You cannot have received any prior cancer treatment for this germinoma, except for surgery or steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat children with brain tumors using proton radiation (a precise type of radiation). It's designed to help the radiation target the tumor while protecting the spine and its ability to grow normally.
This trial tests a new combination treatment for children and young adults with brain tumors that have come back or not responded to standard therapy. The treatment includes a gene therapy (SGT-53) that delivers a normal TP53 gene, a checkpoint inhibitor drug that helps the immune system attack the cancer, and focused radiation. The goal is to see if this combination is safe and can shrink tumors.
This Phase 2 study tests a new treatment approach for certain brain tumors called NGGCT in children and young adults. It may help improve outcomes by targeting tumors in specific brain locations and using tumor marker tests to guide care.
This Phase 2 trial studies WVI for children and young adults with a newly diagnosed germ cell tumor in one side of the basal ganglia/thalamus. It aims to see how well the treatment works for tumors without spread within the brain.
This trial tests a radiation plan that gives treatment in fewer, larger “fractions” using proton beams (or sometimes photon beams) for certain non-cancer brain tumor types. It aims to see how well this approach works while keeping side effects manageable.
This trial tests a combination of chemotherapy drugs (topotecan given into the spine plus maintenance chemo) for children under 6 with high-risk embryonal brain tumors. The goal is to see if this approach can improve outcomes after initial treatment.
Hear when a new Diabetes Insipidus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.